212 related articles for article (PubMed ID: 22093364)
1. Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.
Zhong J; Cao RX; Zu XY; Hong T; Yang J; Liu L; Xiao XH; Ding WJ; Zhao Q; Liu JH; Wen GB
FEBS J; 2012 Jan; 279(2):316-35. PubMed ID: 22093364
[TBL] [Abstract][Full Text] [Related]
2. Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer.
Zhong J; Cao RX; Hong T; Yang J; Zu XY; Xiao XH; Liu JH; Wen GB
Gene; 2011 Nov; 487(1):1-9. PubMed ID: 21820040
[TBL] [Abstract][Full Text] [Related]
3. PRMT2β, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells.
Zhong J; Chen YJ; Chen L; Shen YY; Zhang QH; Yang J; Cao RX; Zu XY; Wen GB
Oncol Rep; 2017 Aug; 38(2):1303-1311. PubMed ID: 28677794
[TBL] [Abstract][Full Text] [Related]
4. Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
Zhong J; Cao RX; Liu JH; Liu YB; Wang J; Liu LP; Chen YJ; Yang J; Zhang QH; Wu Y; Ding WJ; Hong T; Xiao XH; Zu XY; Wen GB
Oncogene; 2014 Nov; 33(48):5546-58. PubMed ID: 24292672
[TBL] [Abstract][Full Text] [Related]
5. PRMT2 and RORγ expression are associated with breast cancer survival outcomes.
Oh TG; Bailey P; Dray E; Smith AG; Goode J; Eriksson N; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Clarke CL; Grimmond S; Dowhan DH; Muscat GE
Mol Endocrinol; 2014 Jul; 28(7):1166-85. PubMed ID: 24911119
[TBL] [Abstract][Full Text] [Related]
6. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
[TBL] [Abstract][Full Text] [Related]
8. Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36.
Shen Y; Zhong J; Liu J; Liu K; Zhao J; Xu T; Zeng T; Li Z; Chen Y; Ding W; Wen G; Zu X; Cao R
Oncol Rep; 2018 Jun; 39(6):2604-2612. PubMed ID: 29620287
[TBL] [Abstract][Full Text] [Related]
9. PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation.
Hu G; Yan C; Xie P; Cao Y; Shao J; Ge J
Exp Cell Res; 2020 Sep; 394(2):112152. PubMed ID: 32574605
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
11. PELP1 oncogenic functions involve CARM1 regulation.
Mann M; Cortez V; Vadlamudi R
Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
[TBL] [Abstract][Full Text] [Related]
12. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
13. Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.
Qi C; Chang J; Zhu Y; Yeldandi AV; Rao SM; Zhu YJ
J Biol Chem; 2002 Aug; 277(32):28624-30. PubMed ID: 12039952
[TBL] [Abstract][Full Text] [Related]
14. Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).
Chaudhri RA; Olivares-Navarrete R; Cuenca N; Hadadi A; Boyan BD; Schwartz Z
J Biol Chem; 2012 Mar; 287(10):7169-81. PubMed ID: 22247547
[TBL] [Abstract][Full Text] [Related]
15. PRMT2 interacts with splicing factors and regulates the alternative splicing of BCL-X.
Vhuiyan MI; Pak ML; Park MA; Thomas D; Lakowski TM; Chalfant CE; Frankel A
J Biochem; 2017 Jul; 162(1):17-25. PubMed ID: 28057797
[TBL] [Abstract][Full Text] [Related]
16. Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells.
Baldwin RM; Morettin A; Paris G; Goulet I; Côté J
Cell Cycle; 2012 Dec; 11(24):4597-612. PubMed ID: 23187807
[TBL] [Abstract][Full Text] [Related]
17. PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression.
Li Z; Chen C; Yong H; Jiang L; Wang P; Meng S; Chu S; Li Z; Guo Q; Zheng J; Bai J; Li H
Cell Death Dis; 2023 May; 14(5):322. PubMed ID: 37173306
[TBL] [Abstract][Full Text] [Related]
18. Interplay between estrogen receptor and AKT in estradiol-induced alternative splicing.
Bhat-Nakshatri P; Song EK; Collins NR; Uversky VN; Dunker AK; O'Malley BW; Geistlinger TR; Carroll JS; Brown M; Nakshatri H
BMC Med Genomics; 2013 Jun; 6():21. PubMed ID: 23758675
[TBL] [Abstract][Full Text] [Related]
19. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells.
Dahlman-Wright K; Qiao Y; Jonsson P; Gustafsson JÅ; Williams C; Zhao C
Carcinogenesis; 2012 Sep; 33(9):1684-91. PubMed ID: 22791811
[TBL] [Abstract][Full Text] [Related]
20. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
Dong F; Li Q; Yang C; Huo D; Wang X; Ai C; Kong Y; Sun X; Wang W; Zhou Y; Liu X; Li W; Gao W; Liu W; Kang C; Wu X
Nat Commun; 2018 Oct; 9(1):4552. PubMed ID: 30382083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
